FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Vito Campese

Research Profile

Disorders

Anatomy

Living Beings

Chemicals & Drugs

Physiology

Concepts & Ideas

Risk Factors

Co-author Network

Publications

TOP 3
Jeanie Park; Holly R Middlekauff; Vito M Campese
Abnormal sympathetic reactivity to the cold pressor test in overweight humans.
Jeanie Park; Vito M Campese
Resistant hypertension and obstructive sleep apnea in end-stage renal disease.
Elaine Ku; Wanwarat Ananthapanyasut; Vito M Campese
IgA nephropathy in a patient with ulcerative colitis, Graves' disease and positive myeloperoxidase ANCA.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Vito Campese (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Jeanie Park; Holly R Middlekauff; Vito M Campese
Abnormal sympathetic reactivity to the cold pressor test in overweight humans.
American journal of hypertension 2012;25(12):1236-41.
2012: Jeanie Park; Vito M Campese
Resistant hypertension and obstructive sleep apnea in end-stage renal disease.
Journal of hypertension 2012;30(5):880-1.
2012: Elaine Ku; Wanwarat Ananthapanyasut; Vito M Campese
IgA nephropathy in a patient with ulcerative colitis, Graves' disease and positive myeloperoxidase ANCA.
Clinical nephrology 2012;77(2):146-50.
2011: Vito M Campese; Elaine Ku; Roberto Bigazzi; Stefano Bianchi
Do HMG-CoA reductase inhibitors improve kidney function? The saga continues.
Journal of nephrology 2011;24(5):550-3.
2011: Vito M Campese; Elaine Ku; Jeanie Park
Sympathetic renal innervation and resistant hypertension.
International journal of hypertension 2011;2011():814354.
2010: Yee Lu; Elaine Ku; Vito M Campese
Aldosterone in the pathogenesis of chronic kidney disease and proteinuria.
Current hypertension reports 2010;12(4):303-6.
2010: Edward L Schneider; Vito M Campese
Adverse drug responses: An increasing threat to the well-being of older patients: Comment on "Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older".
Archives of internal medicine 2010;170(13):1148-9.
2010: Vito M Campese
Oxidative stress and sympathetic activity in hypertension.
American journal of hypertension 2010;23(5):456.
2010: Stefano Bianchi; Roberto Bigazzi; Vito M Campese
Intensive versus conventional therapy to slow the progression of idiopathic glomerular diseases.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2010;55(4):671-81.
2010: Antonio Cioni; Caterina Sordini; Ivo Cavallini; Roberto Bigazzi; Vito M Campese
Angiotensin receptor blocker telmisartan improves insulin sensitivity in peritoneal dialysis patients.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 2010;30(1):66-71.
2009: Elaine Ku; Vito M Campese
Aldosterone and hypertension in African Americans.
American journal of hypertension 2009;22(12):1234.
2009: Elaine Ku; Vito M Campese
Role of aldosterone in the progression of chronic kidney disease and potential use of aldosterone blockade in children.
Pediatric nephrology (Berlin, Germany) 2009;24(12):2301-7.
2009: Elaine Ku; Niloofar Nobakht; Vito M Campese
Lixivaptan: a novel vasopressin receptor antagonist.
Expert opinion on investigational drugs 2009;18(5):657-62.
2009: Yongli Bai; Bahman Jabbari; Shaohua Ye; Vito M Campese; Nosratola D Vaziri
Regional expression of NAD(P)H oxidase and superoxide dismutase in the brain of rats with neurogenic hypertension.
American journal of nephrology 2009;29(5):483-92.
2008: Jeanie Park; Vito M Campese; Niloofar Nobakht; Holly R Middlekauff
Differential distribution of muscle and skin sympathetic nerve activity in patients with end-stage renal disease.
Journal of applied physiology (Bethesda, Md. : 1985) 2008;105(6):1873-6.
2008: Jeanie Park; Vito M Campese; Holly R Middlekauff
Exercise pressor reflex in humans with end-stage renal disease.
American journal of physiology. Regulatory, integrative and comparative physiology 2008;295(4):R1188-94.
2008: Roberto Bigazzi; Stefano Bianchi; Enrica Buoncristiani; Vito M Campese
Increased cardiovascular events in hypertensive patients with insulin resistance: a 13-year follow-up.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2008;18(4):314-9.
2007: Vito M Campese; Jeanie Park
HMG-CoA reductase inhibitors and renal function.
Clinical journal of the American Society of Nephrology : CJASN 2007;2(6):1100-3.
2007: Vito M Campese
Diuretics are preferred over angiotensin II-converting enzyme inhibitors for initial therapy of uncomplicated hypertension.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2007;50(2):197-202.
2007: Vito M Campese; Shaohua Ye
A vitamin-E-fortified diet reduces oxidative stress, sympathetic nerve activity, and hypertension in the phenol-renal injury model in rats.
Journal of the American Society of Hypertension : JASH 2007;1(4):242-50.
2007: Vito M Campese; J Park
HMG-CoA reductase inhibitors and the kidney.
Kidney international 2007;71(12):1215-22.
2007: Vito M Campese; Ram K Sindhu; Shaohua Ye; Yongli Bai; Nosratola D Vaziri; Bahman Jabbari
Regional expression of NO synthase, NAD(P)H oxidase and superoxide dismutase in the rat brain.
Brain research 2007;1134(1):27-32.
2007: Jeanie Park; Vito M Campese
Clinical characteristics of resistant hypertension: the importance of compliance and the role of diagnostic evaluation in delineating pathogenesis.
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(1 Suppl 1):7-12.
2006: Stefano Bianchi; Roberto Bigazzi; Vito M Campese
Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease.
Kidney international 2006;70(12):2116-23.
2006: Vito M Campese; Jeanie Park
The kidney and hypertension: over 70 years of research.
Journal of nephrology 2006;19(6):691-8.
2006: Vito M Campese; Jeanie Park
Use of antagonists of aldosterone in patients with chronic kidney disease: Potential advantages and risks.
Journal of hypertension 2006;24(11):2157-9.
2006: Shaohua Ye; Huiquin Zhong; Swati Yanamadala; Vito M Campese
Oxidative stress mediates the stimulation of sympathetic nerve activity in the phenol renal injury model of hypertension.
Hypertension 2006;48(2):309-15.
2006: Roberto Bigazzi; Stefano Bianchi; Valentina Batini; Daniela Guzzo; Vito M Campese
Metabolic risk factors and markers of cardiovascular and renal damage in overweight subjects.
American journal of hypertension 2006;19(4):426-31.
2006: Vito M Campese; N Mitra; D Sandee
Hypertension in renal parenchymal disease: why is it so resistant to treatment?
Kidney international 2006;69(6):967-73.
2005: Vito M Campese; Bassel Hadaya; Josephine Chiu
HMG-CoA reductase inhibitors and the kidney.
Current hypertension reports 2005;7(5):337-42.
2005: Domenic A Sica; Thomas D Giles; Henry R Black; Vito M Campese
ACE inhibitors: over two decades of use.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(9):531-7.
2005: Vito M Campese; Ye Shaohua; Zhong Huiquin
Oxidative stress mediates angiotensin II-dependent stimulation of sympathetic nerve activity.
Hypertension 2005;46(3):533-9.
2005: Stefano Bianchi; Roberto Bigazzi; Vito M Campese
Antagonists of aldosterone and proteinuria in patients with CKD: an uncontrolled pilot study.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2005;46(1):45-51.
2005: Vito M Campese; Mitra K Nadim; Murray Epstein
Are 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors renoprotective?
Journal of the American Society of Nephrology : JASN 2005;16 Suppl 1():S11-7.
2005: Murray Epstein; Vito M Campese
Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors on renal function.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2005;45(1):2-14.
2004: Mitra K Nadim; Renee Dua; Vito M Campese
Antihypertensive drugs and the kidney.
Current cardiology reports 2004;6(6):403-8.
2004: Vito M Campese; Shaohua Ye; Huiqin Zhong; Vijay Yanamadala; Zhong Ye; Josephine Chiu
Reactive oxygen species stimulate central and peripheral sympathetic nervous system activity.
American journal of physiology. Heart and circulatory physiology 2004;287(2):H695-703.
2004: Mayer B Davidson; Mohsen Bazargan; George L Bakris; Anne Peters Harmel; Vito M Campese; Emad Basta
ImmunoDip: an improved screening method for microalbuminuria.
American journal of nephrology 2004;24(3):284-8.
2004: Murray Epstein; Vito M Campese
Evolving role of calcium antagonists in the management of hypertension.
The Medical clinics of North America 2004;88(1):149-65.
2003: Vito M Campese
A new model of neurogenic hypertension caused by renal injury: pathophysiology and therapeutic implications.
Clinical and experimental nephrology 2003;7(3):167-71.
2003: Li E Yang; Huiqin Zhong; Patrick K K Leong; Anjana Perianayagam; Vito M Campese; Alicia A McDonough
Chronic renal injury-induced hypertension alters renal NHE3 distribution and abundance.
American journal of physiology. Renal physiology 2003;284(5):F1056-65.
2003: Stefano Bianchi; Roberto Bigazzi; Alberto Caiazza; Vito M Campese
A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2003;41(3):565-70.
2003: Li E Yang; Patrick K K Leong; Shaohua Ye; Vito M Campese; Alicia A McDonough
Responses of proximal tubule sodium transporters to acute injury-induced hypertension.
American journal of physiology. Renal physiology 2003;284(2):F313-22.
2003: Stefano Bianchi; Roberto Bigazzi; A Amoroso; Vito M Campese
Silent ischemia is more prevalent among hypertensive patients with microalbuminuria and salt sensitivity.
Journal of human hypertension 2003;17(1):13-20.
2002: Shaohua Ye; Huiqin Zhong; Vijay Yanamadala; Vito M Campese
Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity.
American journal of hypertension 2002;15(8):717-24.
2002: Vito M Campese; Pantea Mozayeni; Shaohua Ye; Michael Gumbard
High salt intake inhibits nitric oxide synthase expression and aggravates hypertension in rats with chronic renal failure.
Journal of nephrology 2002;15(4):407-13.
2002: Carlos M Ferrario; Ronald D Smith; Bridget Brosnihan; Mark C Chappell; Vito M Campese; Ole Vesterqvist; Wei-chi Liao; Michael C Ruddy; Clarence Grim
Effects of omapatrilat on the renin-angiotensin system in salt-sensitive hypertension.
American journal of hypertension 2002;15(6):557-64.
2002: Shaohua Ye; Huiquin Zhong; Vu Ngoc Duong; Vito M Campese
Losartan reduces central and peripheral sympathetic nerve activity in a rat model of neurogenic hypertension.
Hypertension 2002;39(6):1101-6.
2002: Vito M Campese; Ewa Krol
Neurogenic factors in renal hypertension.
Current hypertension reports 2002;4(3):256-60.
2002: Vito M Campese; Shaohua Ye; Huiquin Zhong
Downregulation of neuronal nitric oxide synthase and interleukin-1beta mediates angiotensin II-dependent stimulation of sympathetic nerve activity.
Hypertension 2002;39(2 Pt 2):519-24.
2001: Vito M Campese; K C Lasseter; Carlos M Ferrario; W B Smith; M C Ruddy; Clarence Grim; Ronald D Smith; R Vargas; M F Habashy; Ole Vesterqvist; CL Delaney; Wei-chi Liao
Omapatrilat versus lisinopril: efficacy and neurohormonal profile in salt-sensitive hypertensive patients.
Hypertension 2001;38(6):1342-8.
2000: Shaohua Ye; Pantea Mozayeni; M Gamburd; Huiquin Zhong; Vito M Campese
Interleukin-1beta and neurogenic control of blood pressure in normal rats and rats with chronic renal failure.
American journal of physiology. Heart and circulatory physiology 2000;279(6):H2786-96.
2000: Vito M Campese; Shaohua Ye; R H Truong; M Gamburd
Losartan reduces sympathetic nerve outflow from the brain of rats with chronic renal failure.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2000;1(2):202-8.
2000: Vito M Campese
The kidney and the neurogenic control of blood pressure in renal disease.
Journal of nephrology 2000;13(3):221-4.
2000: Vito M Campese
Neurogenic factors and hypertension in renal disease.
Kidney international. Supplement 2000;75():S2-6.
1999: Stefano Bianchi; Roberto Bigazzi; Vito M Campese
Microalbuminuria in essential hypertension: significance, pathophysiology, and therapeutic implications.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1999;34(6):973-95.
1999: Vito M Campese; Stefano Bianchi; Roberto Bigazzi
Association between hyperlipidemia and microalbuminuria in essential hypertension.
Kidney international. Supplement 1999;71():S10-3.
1999: Vito M Campese
Salt-sensitive hypertension: renal and cardiovascular implications.
Nutrition, metabolism, and cardiovascular diseases : NMCD 1999;9(3):143-56.
1999: Vito M Campese; Saeid Nosrati
Diagnosis and evaluation of secondary hypertension.
Clinical cornerstone 1999;2(1):27-39.
1998: Vito M Campese; A Wurgaft; M Safa; Stefano Bianchi
Dietary salt intake, blood pressure and the kidney in hypertensive patients with non-insulin dependent diabetes mellitus.
Journal of nephrology 1998;11(6):289-95.
1998: Roberto Bigazzi; Stefano Bianchi; D Baldari; Vito M Campese
Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension.
Journal of hypertension 1998;16(9):1325-33.
1998: Shaohua Ye; M Gamburd; Pantea Mozayeni; Michael Koss; Vito M Campese
A limited renal injury may cause a permanent form of neurogenic hypertension.
American journal of hypertension 1998;11(6 Pt 1):723-8.
1997: Stefano Bianchi; Roberto Bigazzi; R Nenci; Vito M Campese
Hyperinsulinemia, circadian variation of blood pressure and end-organ damage in hypertension.
Journal of nephrology 1997;10(6):325-33.
1997: Vito M Campese; M Amar; C Anjali; T Medhat; A Wurgaft
Effect of L-arginine on systemic and renal haemodynamics in salt-sensitive patients with essential hypertension.
Journal of human hypertension 1997;11(8):527-32.
1997: Stefano Bianchi; Roberto Bigazzi; Vito M Campese
Microalbuminuria in essential hypertension.
Journal of nephrology 1997;10(4):216-9.
1997: Vito M Campese
Neurogenic factors and hypertension in chronic renal failure.
Journal of nephrology 1997;10(4):184-7.
1997: Vito M Campese
Why is salt-sensitive hypertension so common in blacks?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1997;12(3):399-403.
1997: Shaohua Ye; Burak M Ozgur; Vito M Campese
Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure.
Kidney international 1997;51(3):722-7.
1997: Shaohua Ye; Saeid Nosrati; Vito M Campese
Nitric oxide (NO) modulates the neurogenic control of blood pressure in rats with chronic renal failure (CRF).
The Journal of clinical investigation 1997;99(3):540-8.
1997: Vito M Campese; Stefano Bianchi; Roberto Bigazzi
Hypertension, hyperlipidemia and microalbuminuria.
Contributions to nephrology 1997;120():11-21.
1996: Vito M Campese; M Tawadrous; Roberto Bigazzi; Stefano Bianchi; A S Mann; S Oparil; Leopoldo Raij
Salt intake and plasma atrial natriuretic peptide and nitric oxide in hypertension.
Hypertension 1996;28(3):335-40.
1996: Vito M Campese
The kidney in the hypertensive black.
Ethnicity & health 1996;1(2):145-51.
1996: MF Gadallah; Mohamed El-Shahawy; Vito M Campese; J R Todd; J W King
Disparate prognosis of thrombotic microangiopathy in HIV-infected patients with and without AIDS.
American journal of nephrology 1996;16(5):446-50.
1996: Mohamed El-Shahawy; C Mesa; Michael Koss; Vito M Campese
A 19-year-old female with fever, acroparesthesia, and progressive deterioration of renal function.
American journal of nephrology 1996;16(5):417-24.
1996: Roberto Bigazzi; S Bianchi; G Baldari; Vito M Campese
Clustering of cardiovascular risk factors in salt-sensitive patients with essential hypertension: role of insulin.
American journal of hypertension 1996;9(1):24-32.
1996: Vito M Campese; Stefano Bianchi
Is deterioration of renal function in essential hypertension predictable?
Contributions to nephrology 1996;119():83-90.
1995: Vito M Campese; E Kogosov; Michael Koss
Renal afferent denervation prevents the progression of renal disease in the renal ablation model of chronic renal failure in the rat.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1995;26(5):861-5.
1995: Roberto Bigazzi; S Bianchi; R Nenci; D Baldari; G Baldari; Vito M Campese
Increased thickness of the carotid artery in patients with essential hypertension and microalbuminuria.
Journal of human hypertension 1995;9(10):827-33.
1995: Vito M Campese; E Kogosov
Renal afferent denervation prevents hypertension in rats with chronic renal failure.
Hypertension 1995;25(4 Pt 2):878-82.
1994: Vito M Campese
Neurogenic factors in hypertension: therapeutic implications.
Annali italiani di medicina interna : organo ufficiale della Società italiana di medicina interna 1994;9 Suppl():39S-43S.
1994: S Bianchi; Roberto Bigazzi; C Valtriani; I Chiapponi; G Sgherri; G Baldari; Andrea Natali; Ele Ferrannini; Vito M Campese
Elevated serum insulin levels in patients with essential hypertension and microalbuminuria.
Hypertension 1994;23(6 Pt 1):681-7.
1994: Roberto Bigazzi; E Kogosov; Vito M Campese
Altered norepinephrine turnover in the brain of rats with chronic renal failure.
Journal of the American Society of Nephrology : JASN 1994;4(11):1901-7.
1994: Roberto Bigazzi; E Kogosov; Vito M Campese
Altered norepinephrine turnover in the brown fat of rats with chronic renal failure.
Journal of the American Society of Nephrology : JASN 1994;4(11):1896-900.
1994: Vito M Campese
Salt sensitivity in hypertension. Renal and cardiovascular implications.
Hypertension 1994;23(4):531-50.
1994: Roberto Bigazzi; S Bianchi; D Baldari; G Sgherri; G Baldari; Vito M Campese
Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors.
Hypertension 1994;23(2):195-9.
1994: S Bianchi; Roberto Bigazzi; G Baldari; G Sgherri; Vito M Campese
Diurnal variations of blood pressure and microalbuminuria in essential hypertension.
American journal of hypertension 1994;7(1):23-9.
1994: Mohamed El-Shahawy; MF Gadallah; Vito M Campese
Tuberculosis of the spine (Pott's disease) in patients with end-stage renal disease.
American journal of nephrology 1994;14(1):55-9.
1993: Vito M Campese; F Karubian; Roberto Bigazzi
Hemodynamic alterations and urinary albumin excretion in patients with essential hypertension.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1993;21(5 Suppl 2):15-21.
1993: Vito M Campese; F Karubian; I Chervu; M Parise; N Sarkies; Roberto Bigazzi
Pressor reactivity to norepinephrine and angiotensin in salt-sensitive hypertensive patients.
Hypertension 1993;21(3):301-7.
1993: Roberto Bigazzi; S Bianchi; D Baldari; G Sgherri; G Baldari; Vito M Campese
Long-term effects of a converting enzyme inhibitor and a calcium channel blocker on urinary albumin excretion in patients with essential hypertension.
American journal of hypertension 1993;6(2):108-13.
1993: MF Gadallah; Mohamed El-Shahawy; Vito M Campese
Unilateral breast enlargement secondary to hemodialysis arteriovenous fistula and subclavian vein occlusion.
Nephron 1993;63(3):351-3.
1992: S Bianchi; Roberto Bigazzi; G Baldari; Vito M Campese
Microalbuminuria in patients with essential hypertension: effects of several antihypertensive drugs.
The American journal of medicine 1992;93(5):525-8.
1992: MF Gadallah; B Ahmad; F Karubian; Vito M Campese
Pregnancy in patients on chronic ambulatory peritoneal dialysis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1992;20(4):407-10.
1992: J M Alexiewicz; Z Gaciong; M Parise; F Karubian; Shaul G Massry; Vito M Campese
Effect of dietary sodium intake on intracellular calcium in lymphocytes of salt-sensitive hypertensive patients.
American journal of hypertension 1992;5(8):536-41.
1992: Roberto Bigazzi; S Bianchi; Vito M Campese; G Baldari
Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension.
Nephron 1992;61(1):94-7.
1992: C L Liu; Roberto Bigazzi; J Ballard; Vito M Campese
Effect of hypercalcemia on renal sympathetic nervous system activity.
American journal of nephrology 1992;12(1-2):86-93.
1991: Vito M Campese; M Parise; F Karubian; Roberto Bigazzi
Abnormal renal hemodynamics in black salt-sensitive patients with hypertension.
Hypertension 1991;18(6):805-12.
1991: Vito M Campese; F Karubian
Renal consequences of salt and hypertension.
Seminars in nephrology 1991;11(5):549-60.
1991: Vito M Campese; F Karubian
Salt sensitivity in hypertension: implications for the kidney.
Journal of the American Society of Nephrology : JASN 1991;2(2 Suppl 1):S53-61.
1991: MF Gadallah; Shaul G Massry; Roberto Bigazzi; R L Horst; P Eggena; Vito M Campese
Intestinal absorption of calcium and calcium metabolism in patients with essential hypertension and normal renal function.
American journal of hypertension 1991;4(5 Pt 1):404-9.
1991: Vito M Campese; Roberto Bigazzi
The role of hypertension in the progression of renal diseases.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1991;17(5 Suppl 1):43-7.
1991: S Bianchi; Roberto Bigazzi; G Baldari; Vito M Campese
Microalbuminuria in patients with essential hypertension. Effects of an angiotensin converting enzyme inhibitor and of a calcium channel blocker.
American journal of hypertension 1991;4(4 Pt 1):291-6.
1991: S Bianchi; Roberto Bigazzi; G Baldari; Vito M Campese
Long-term effects of enalapril and nicardipine on urinary albumin excretion in patients with chronic renal insufficiency: a 1-year follow-up.
American journal of nephrology 1991;11(2):131-7.
1991: I Chervu; Michael Koss; Vito M Campese
Bilateral renal cortical necrosis in two patients with Neisseria meningitidis sepsis.
American journal of nephrology 1991;11(5):411-5.
1990: Vito M Campese; C L Liu
Sexual dysfunction in uremia. Endocrine and neurological alterations.
Contributions to nephrology 1990;77():1-14.
1990: Vito M Campese
Autonomic nervous system dysfunction in uraemia.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1990;5 Suppl 1():98-101.
1989: Miroslaw Smogorzewski; Vito M Campese; Shaul G Massry
Abnormal norepinephrine uptake and release in brain synaptosomes in chronic renal failure.
Kidney international 1989;36(3):458-65.
1989: Vito M Campese
Calcium, parathyroid hormone, and blood pressure.
American journal of hypertension 1989;2(2 Pt 2):34S-44S.
1989: Vito M Campese; C Liu
Antihypertensive therapy and progression of renal failure.
Contributions to nephrology 1989;75():155-66.
1988: G Z Fadda; Shaul G Massry; M el-Refai; Vito M Campese
Alpha 1 adrenergic receptors in mesenteric arteries of rats with chronic renal failure.
Kidney international 1988;34(4):463-6.
1988: Vito M Campese
Orthostatic hypotension: idiopathic and uremic.
Kidney international. Supplement 1988;25():S152-5.
1988: Vito M Campese
Cardiovascular instability during hemodialysis.
Kidney international. Supplement 1988;24():S186-90.